Primary record
2,7,10,12-Tetraazatridecanoic acid, 12-methyl-13-[2-(1-methylethyl)-4-thiazolyl]-9-[2-(4-morpholinyl)ethyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3R,6R,9S)-; Cobicistat; GS 9350
- 库存
- 7,065 克
- 纯度
- 98.9 %
- CAS
- 1004316-88-4
化合物标识与属性
- CAS
- 1004316-88-4
- PubChem CID
- 25151504
- SMILES
- CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5
- Canonical SMILES
- CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1
名称与同义词
- Cobicistat
- Tybost
- 1004316-88-4
- Cobicistat (GS-9350)
- cobicistatum
- ?Cobicistat
- GS-9350
- Cobicistat [USAN]
- Cobicistat,GS-9350
- Cobicistat/darunavir
- Tybost (TN)
- COBI
- GS 9350
- UNII-LW2E03M5PG
- Cobicistat (Standard)
- Cobicistat [USAN:INN]
- LW2E03M5PG
- A1APA
- COBICISTAT [MI]
- RefChem:56763
- MFCD18251449
- COBICISTAT [INN]
- COBICISTAT [JAN]
- Cobicistat, GS-9350
- Cobicistat; GS-9350
- COBICISTAT [VANDF]
- COBICISTAT, (R,R,S)-
- CHEBI:72291
- D02VJP
- D0V4ZN
- COBICISTAT [WHO-DD]
- Cobicistat on silicon dioxide
- Cobicistat (JAN/USAN/INN)
- DTXSID00143269
- EVOTAZ COMPONENT COBICISTAT
- GENVOYA COMPONENT COBICISTAT
- GTPL7535
- orb1300941
- SCHEMBL2736227
- SYMTUZA COMPONENT COBICISTAT
- CHEMBL2095208
- COBICISTAT [ORANGE BOOK]
- DTXCID1065760
- REZOLSTA COMPONENT COBICISTAT
- STRIBILD COMPONENT COBICISTAT
- PREZCOBIX COMPONENT COBICISTAT
- QCR-199
- V03AX03
- C40H53N7O5S2
- GS9350
- ZCIGNRJZKPOIKD-CQXVEOKZSA-N
- GLXC-90002
- AOB87771
- BCP06630
- EX-A2578
- BDBM50447471
- EBC-27460
- HY-10493R
- s2900
- ZINC85537014
- 9350, GS
- AKOS025404908
- CCG-270459
- CS-0742
- CS-O-01242
- DB09065
- FM40808
- KS-00000T52
- NCGC00386235-04
- NCGC00386235-06
- AC-28961
- AS-17061
- CID:25151504
- DA-72306
- HY-10493
- SY111951
- SID:441532667
- AB0093115
- A4313
- SW219553-1
- J3.033.505H
- A11277
- D09881
- 2,7,10,12-Tetraazatridecanoic acid, 12-methyl-13-[2-(1-methylethyl)-4-thiazolyl]-9-[2-(4-morpholinyl)ethyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3R,6R,9S)-
- AB01566899_01
- EN300-7404993
- thiazol-5-ylmethyl ((2R,5R)-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanamido)-1,6-diphenylhexan-2-yl)carbamate
- A854802
- 1,3-thiazol-5-ylmethyl N-[(2R,5R)-5-[[(2S)-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]-4-morpholin-4-ylbutanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
- Q5138908
- BRD-K51040301-001-02-1
- D000069547
- B0084-456314
- 1,3-thiazol-5-ylmethyl [(2R,5R)-5-{[(2S)-2-({[(2-isopropyl-1,3-thiazol-4-yl)methyl](methyl)carbamoyl}amino)-4-(morpholin-4-yl)butanoyl]amino}-1,6-diphenylhexan-2-yl]carbamate
- 1,3-thiazol-5-ylmethyl N-[(2R,5R)-5-[(2S)-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}-4-(morpholin-4-yl)butanamido]-1,6-diphenylhexan-2-yl]carbamate
- 2,7,10,12-Tetraazatridecanoic acid, 12-methyl-13-(2-(1-methylethyl)-4-thiazolyl)-9-(2-(4-morpholinyl)ethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3R,6R,9S)-
- thiazol-5-ylmethyl (2R,5R)-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanamido)-1,6-diphenylhexan-2-ylcarbamate
- (1,3-thiazol-5-yl)methyl N-[(2R,5R)-5-[(2S)-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}-4-(morpholin-4-yl)butanamido]-1,6-diphenylhexan-2-yl]carbamate
- thiazol-5-ylmethyl N-[(1R,4R)-1-benzyl-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-4-morpholino-butanoyl]amino]-5-phenyl-pentyl]carbamate
- (1,3-THIAZOL-5-YL)METHYL (5S,8R,11R)-8,11-DIBENZYL-2-METHYL-5-(2-(MORPHOLIN-4-YL)ETHYL)-1-(2-(PROPAN-2-YL)-1,3-THIAZOL-4-YL)-3,6-DIOXO-2,4,7,12-TETRAAZATRIDECAN-13-OATE
- (1,3-Thiazol-5-yl)methyl {(2R,5R)-5-[(2S)-2-[(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)amino]-4-(morpholin-4-yl)butanamido]-1,6-diphenylhexan-2-yl}carbamate
- (3R,6R,9S)-12-Methyl-13-(2-isopropyl-4-thiazolyl)-9-(2-morpholinoethyl)-8,11-dioxo-3,6-dibenzyl-2,7,10,12-tetraazatridecanoic acid 5-thiazolylmethyl ester
- (3R,6R,9S)-2-Methyl-13-[2-(1-methylethyl)-4-thiazolyl]-9-[2-(4-morpholin yl)ethyl]-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoic acid 5-thiazolylmethyl ester
- [(2R,5R)-5-[[(2S)-2-[3-Methyl-3-[[2-(1-methylethyl)thiazol-4-yl]methyl]ureido]-4-morpholinobutyryl]amino]-1,6-diphenylhexane-2-yl]carbamic acid 5-thiazolylmethyl ester
- 1,3-thiazol-5-ylmethyl ((2R,5R)-5-(((2S)-2-((((2-isopropyl-1,3-thiazol-4-yl)methyl)(methyl)carbamoyl)amino)-4-(morpholin-4-yl)butanoyl)amino)-1,6-diphenylhexan-2-yl)carbamate
- 1,3-THIAZOL-5-YLMETHYL ((2R,5R)-5-(((2S)-2-((METHYL((2-(PROPAN-2-YL)-1,3-THIAZOL-4-YL)METHYL)CARBAMOYL)AMINO)-4-(MORPHOLIN-4-YL)BUTANOYL)AMINO)-1,6-DIPHENYLHEXAN-2-YL)CARBAMATE
- 1,3-thiazol-5-ylmethyl N-((2R,5R)-5-(((2S)-2-((methyl-((2-propan-2-yl-1,3-thiazol-4-yl)methyl)carbamoyl)amino)-4-morpholin-4-ylbutanoyl)amino)-1,6-diphenylhexan-2-yl)carbamate
- 2,7,10,12-Tetraazatridecanoic acid, 12-methyl-13-[2-(1-methylethyl)-4-thiazolyl]-9-[2-(4-morpholinyl)ethyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3R,6R,9S)-; Cobicistat; GS 9350
- 5-Thiazolylmethyl [(2R,5R)-5-[(S)-2-[3-[(2-Isopropyl-4-thiazolyl)methyl]-3-methylureido]-4-morpholinobutanamido]-1,6-diphenyl-2-hexyl]carbamate
- Thiazol-5-ylmethyl ((1R,4R)-1-benzyl-4-({(2S)-2-((methyl{(2-(1-methylethyl)thiazol-4-yl)methyl}carbamoyl)amino)-4-(morpholin-4-yl)butanoyl}amino)-5-phenylpentyl)carbamate